We know antiretroviral therapy can prevent HIV infection, but can natural biological substances do the same? The results of a recent scientific trial have answered this question: Yes, using broadly neutralising antibodies. But what are broadly neutralising antibodies? How do they work? And when will the average person get access to them? Amy Green breaks down the science.
Results of a “proof of concept” study presented at the virtual 4th Research for HIV Prevention Conference last week showed that one particular broadly neutralising monoclonal antibody (bNab) – called VRC01 – prevented HIV infection in over 70% of people exposed to strains of HIV that is sensitive to this particular bNab.
Press release content from Business Wire. The AP news staff was not involved in its creation.
NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board
February 8, 2021 GMT
Regulatory News:
NOXXON Pharma N.V.
(Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the appointment of four leading pancreatic cancer experts to its Scientific Advisory Board (SAB). Led by the newly appointed Chair, Dr. Jose Saro, the SAB will provide strategic and scientific counsel to NOXXON’s clinical programs in this indication.
“These prominent research leaders bring long-standing clinical expertise, cutting-edge scientific knowledge, and a track record of successfully developing new drugs to treat this devastating disease. They fully understand the challenges of developing new drugs for pancreas cancer where the tumor microenvironment plays a large role in resisting ant
A global effort is unraveling many mysteries around the Covid-19 virus. During the course of the pandemic society has adapted quickly, turning many aspects of every day life upside down. Virologists have warned that Covid-19 inoculation isn’t a silver bullet, as the virus will continue to mutate. Thomas Frieden, former director of the US Centres for Disease Control and Prevention says society must accept that this disease is here to stay. As people grieve a previous way of life, we must also adopt long term changes. Daniela Hernandez and Drew Hinshaw of The Wall Street Journal look to the future and how we will live with Covid-19 after the pandemic. – Melani Nathan
Treatment of a COVID-19 patient who had a suppressed immune system with convalescent plasma coincided with the emergence of different variants of the novel coronavirus, says a new case study.